While survival rates soar for other cancers, funding gaps limit progress on cervical and uterine cancer

US-HEALTH-PEOPLE-RESEARCH-CANCER-pharmaceutical

Photo credit should read SAUL LOEB/AFP via Getty Images

The survival rates for cervical and uterine cancer have been stagnant for years, even as the number of deaths from cancer in the United States dropped overall. This week, the American Cancer Society announced the largest reduction in cancer deaths ever reported in a single year, dropping by 2.2 percent in 2017. But while treatments have improved dramatically for many forms of cancer, these particular cancers are left behind for a number of reasons, including gaps in treatment and limited research funding for the diseases.

“I hope this data demonstrates that there needs to be more attention given to these diseases,” says Sarah Temkin, a gynecologic oncologist at Anne Arundel Medical Center in Maryland. “At every level, gynecological…

Continue reading…

via The Verge – All Posts

Check out the Finding Your Identity Podcast!